Trademark: 79215947
Status Date
Tuesday, January 22, 2019
Registration Number
5658412
Registration Date
Tuesday, January 22, 2019
Filing Date
Thursday, April 6, 2017
Published for Opposition
Tuesday, November 6, 2018
5 Preparations for pharmaceutical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); preparations for medical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); diagnostic preparations for medical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); chemical reagents for medical purposes; preparations for analysis for medical purposes, namely, for the treatment of ischemic disorders and diseases, stroke and subarachnoid hemorrhage and delayed cerebral ischemia (DCI)
42 Scientific and technological services, namely, scientific research, in the field of developing methods for the treatment, prevention and alleviation of stroke; industrial analysis and research in the field of development methods for treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia; basic research and clinical research in the field of development of medicaments
Jan 22, 2024
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 12, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2021
Teas Change Of Correspondence Received
Jul 12, 2021
Teas Change Of Domestic Representatives Address
Jul 12, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 12, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 12, 2021
Teas Change Of Owner Address Received
May 31, 2019
Final Decision Transaction Processed By Ib
May 15, 2019
Final Disposition Notice Sent To Ib
May 15, 2019
Final Disposition Processed
Apr 22, 2019
Final Disposition Notice Created, To Be Sent To Ib
Jan 25, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 25, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 22, 2019
Registered-Principal Register
Nov 6, 2018
Official Gazette Publication Confirmation E-Mailed
Nov 6, 2018
Published For Opposition
Nov 2, 2018
Notification Processed By Ib
Oct 17, 2018
Notification Of Possible Opposition Sent To Ib
Oct 17, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 17, 2018
Notification Of Notice Of Publication E-Mailed
Sep 27, 2018
Approved For Pub - Principal Register
Sep 27, 2018
Examiner's Amendment Entered
Sep 27, 2018
Notification Of Examiners Amendment E-Mailed
Sep 27, 2018
Examiners Amendment E-Mailed
Sep 27, 2018
Examiners Amendment -Written
Sep 17, 2018
Notification Of Non-Final Action E-Mailed
Sep 17, 2018
Non-Final Action E-Mailed
Sep 17, 2018
Non-Final Action Written
Sep 6, 2018
Teas Change Of Correspondence Received
Aug 31, 2018
Teas/Email Correspondence Entered
Aug 31, 2018
Correspondence Received In Law Office
Aug 30, 2018
Teas Request For Reconsideration Received
Aug 28, 2018
Teas Change Of Correspondence Received
Aug 28, 2018
Teas/Email Correspondence Entered
Aug 28, 2018
Correspondence Received In Law Office
Aug 28, 2018
Teas Request For Reconsideration Received
Apr 16, 2018
Notification Of Final Refusal Emailed
Apr 16, 2018
Final Refusal E-Mailed
Apr 16, 2018
Final Refusal Written
Mar 21, 2018
Teas/Email Correspondence Entered
Mar 21, 2018
Correspondence Received In Law Office
Mar 18, 2018
Assigned To Lie
Mar 6, 2018
Teas Response To Office Action Received
Feb 8, 2018
New Representative At Ib Received
Oct 29, 2017
Refusal Processed By Ib
Sep 20, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Sep 20, 2017
Refusal Processed By Mpu
Sep 15, 2017
Application Filing Receipt Mailed
Sep 14, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Sep 13, 2017
Non-Final Action Written
Sep 11, 2017
Assigned To Examiner
Sep 11, 2017
New Application Office Supplied Data Entered
Sep 7, 2017
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
